Marina Biotech, Inc. (MRNA) Reports Q3 Loss of $0.05

Marina Biotech, Inc. (NASDAQ: MRNA) reported Q3 EPS of ($0.05), versus ($0.39) reported last year. Revenue for the quarter came in at $286 thousand, versus $1.13 million reported last year.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Moderna (MRNA) call put ratio 1 call to 1.1 puts amid wide price movement
• McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
• Moderna: Citi says oncology optimism is priced in, cuts rating to sell